Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001144204-16-140716

Options or other derivatives

  • Director acquired 2,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
HILL DAVID LOUIS Director 2016-12-20 Grant or award · Share Option (Right to Buy) +2,500 2,500 D: show line 1 in the form
Loading xslF345X03/v455480_4.xml…